APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human aFGF

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human aFGF Industry Growth and Trends Forecast to 2032

8 January 2026104 pages

Choose your research edition.

Industry ResearchRecombinant Human aFGF Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human aFGF Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Recombinant Human aFGF Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human aFGF Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human aFGF Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Recombinant Human aFGF market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human aFGF is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human aFGF is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human aFGF is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human aFGF include Merck, MP Biomedicals, Proteintech, InVitria, Sino Biological, Reprokine, ACROBiosystems, Assay Genie and Cell Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human aFGF market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human aFGF market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human aFGF market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human aFGF.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human aFGF market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human aFGF Market by Company

Merck

MP Biomedicals

Proteintech

InVitria

Sino Biological

Reprokine

ACROBiosystems

Assay Genie

Cell Biologics

Sartorius AG

Yeasen

MedChemExpress

Abcam

Basic Pharma

Recombinant Human aFGF Segment by Type

Acidic

Alkaline

Recombinant Human aFGF Segment by Application

Biopharmaceuticals

Cell Culture & Regenerative Medicine

In Vitro Diagnostics

Others

Recombinant Human aFGF Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human aFGF market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human aFGF and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human aFGF.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human aFGF manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human aFGF in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Acidic Table 2. Major Company of Alkaline Table 3. Global Recombinant Human aFGF Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Human aFGF Sales by Type (2021-2026) & (k units) Table 5. Global Recombinant Human aFGF Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Human aFGF Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Human aFGF Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Human aFGF Price by Type (2021-2026) & (USD/unit) Table 9. Global Recombinant Human aFGF Sales by Type (2027-2032) & (k units) Table 10. Global Recombinant Human aFGF Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Human aFGF Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Human aFGF Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Human aFGF Price by Type (2027-2032) & (USD/unit) Table 14. North America Recombinant Human aFGF Sales by Type (2021-2026) & (k units) Table 15. North America Recombinant Human aFGF Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Human aFGF Sales by Type (2021-2026) & (k units) Table 17. Europe Recombinant Human aFGF Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Human aFGF Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Recombinant Human aFGF Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Human aFGF Sales by Type (2021-2026) & (k units) Table 21. Latin America Recombinant Human aFGF Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Human aFGF Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Recombinant Human aFGF Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Human aFGF Industry Trends Table 25. Recombinant Human aFGF Industry Drivers Table 26. Recombinant Human aFGF Industry Opportunities and Challenges Table 27. Recombinant Human aFGF Industry Restraints Table 28. Global Recombinant Human aFGF Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Human aFGF Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Human aFGF Sales by Company (2021-2026) & (k units) Table 31. Global Recombinant Human aFGF Sales Share by Company (2021-2026) Table 32. Global Recombinant Human aFGF Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Recombinant Human aFGF Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Human aFGF Major Company Production Sites and Headquarters Table 35. Global Recombinant Human aFGF Company, Product Type & Application Table 36. Global Recombinant Human aFGF Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Human aFGF by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Human aFGF Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Human aFGF Sales by Region (2021-2026) & (k units) Table 41. Global Recombinant Human aFGF Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Human aFGF Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Human aFGF Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Human aFGF Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Recombinant Human aFGF Sales by Region (2027-2032) & (k units) Table 46. Global Recombinant Human aFGF Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Human aFGF Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Human aFGF Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Human aFGF Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Recombinant Human aFGF Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Human aFGF Sales by Application (2021-2026) & (k units) Table 52. Global Recombinant Human aFGF Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Human aFGF Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Human aFGF Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Human aFGF Price by Application (2021-2026) & (USD/unit) Table 56. Global Recombinant Human aFGF Sales by Application (2027-2032) & (k units) Table 57. Global Recombinant Human aFGF Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Human aFGF Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Human aFGF Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Human aFGF Price by Application (2027-2032) & (USD/unit) Table 61. North America Recombinant Human aFGF Sales by Application (2021-2026) & (k units) Table 62. North America Recombinant Human aFGF Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Human aFGF Sales by Application (2021-2026) & (k units) Table 64. Europe Recombinant Human aFGF Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Human aFGF Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Recombinant Human aFGF Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Human aFGF Sales by Application (2021-2026) & (k units) Table 68. Latin America Recombinant Human aFGF Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Human aFGF Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Recombinant Human aFGF Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Merck Recombinant Human aFGF Product Portfolio Table 75. Merck Recent Development Table 76. MP Biomedicals Company Information Table 77. MP Biomedicals Business Overview Table 78. MP Biomedicals Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. MP Biomedicals Recombinant Human aFGF Product Portfolio Table 80. MP Biomedicals Recent Development Table 81. Proteintech Company Information Table 82. Proteintech Business Overview Table 83. Proteintech Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Proteintech Recombinant Human aFGF Product Portfolio Table 85. Proteintech Recent Development Table 86. InVitria Company Information Table 87. InVitria Business Overview Table 88. InVitria Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. InVitria Recombinant Human aFGF Product Portfolio Table 90. InVitria Recent Development Table 91. Sino Biological Company Information Table 92. Sino Biological Business Overview Table 93. Sino Biological Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sino Biological Recombinant Human aFGF Product Portfolio Table 95. Sino Biological Recent Development Table 96. Reprokine Company Information Table 97. Reprokine Business Overview Table 98. Reprokine Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Reprokine Recombinant Human aFGF Product Portfolio Table 100. Reprokine Recent Development Table 101. ACROBiosystems Company Information Table 102. ACROBiosystems Business Overview Table 103. ACROBiosystems Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. ACROBiosystems Recombinant Human aFGF Product Portfolio Table 105. ACROBiosystems Recent Development Table 106. Assay Genie Company Information Table 107. Assay Genie Business Overview Table 108. Assay Genie Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Assay Genie Recombinant Human aFGF Product Portfolio Table 110. Assay Genie Recent Development Table 111. Cell Biologics Company Information Table 112. Cell Biologics Business Overview Table 113. Cell Biologics Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Cell Biologics Recombinant Human aFGF Product Portfolio Table 115. Cell Biologics Recent Development Table 116. Sartorius AG Company Information Table 117. Sartorius AG Business Overview Table 118. Sartorius AG Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Sartorius AG Recombinant Human aFGF Product Portfolio Table 120. Sartorius AG Recent Development Table 121. Yeasen Company Information Table 122. Yeasen Business Overview Table 123. Yeasen Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Yeasen Recombinant Human aFGF Product Portfolio Table 125. Yeasen Recent Development Table 126. MedChemExpress Company Information Table 127. MedChemExpress Business Overview Table 128. MedChemExpress Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. MedChemExpress Recombinant Human aFGF Product Portfolio Table 130. MedChemExpress Recent Development Table 131. Abcam Company Information Table 132. Abcam Business Overview Table 133. Abcam Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Abcam Recombinant Human aFGF Product Portfolio Table 135. Abcam Recent Development Table 136. Basic Pharma Company Information Table 137. Basic Pharma Business Overview Table 138. Basic Pharma Recombinant Human aFGF Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Basic Pharma Recombinant Human aFGF Product Portfolio Table 140. Basic Pharma Recent Development Table 141. North America Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Recombinant Human aFGF Sales by Country (2021-2026) & (k units) Table 143. North America Recombinant Human aFGF Sales Market Share by Country (2021-2026) Table 144. North America Recombinant Human aFGF Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Recombinant Human aFGF Sales Market Share Forecast by Country (2027-2032) Table 146. North America Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Recombinant Human aFGF Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Recombinant Human aFGF Market Share by Country (2021-2026) Table 149. North America Recombinant Human aFGF Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Recombinant Human aFGF Market Share Forecast by Country (2027-2032) Table 151. Europe Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Recombinant Human aFGF Sales by Country (2021-2026) & (k units) Table 153. Europe Recombinant Human aFGF Sales Market Share by Country (2021-2026) Table 154. Europe Recombinant Human aFGF Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Recombinant Human aFGF Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Recombinant Human aFGF Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Recombinant Human aFGF Market Share by Country (2021-2026) Table 159. Europe Recombinant Human aFGF Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Recombinant Human aFGF Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Recombinant Human aFGF Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Recombinant Human aFGF Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Recombinant Human aFGF Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Recombinant Human aFGF Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Recombinant Human aFGF Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Recombinant Human aFGF Market Share by Country (2021-2026) Table 169. Asia-Pacific Recombinant Human aFGF Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Recombinant Human aFGF Market Share Forecast by Country (2027-2032) Table 171. Latin America Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Recombinant Human aFGF Sales by Country (2021-2026) & (k units) Table 173. Latin America Recombinant Human aFGF Sales Market Share by Country (2021-2026) Table 174. Latin America Recombinant Human aFGF Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Recombinant Human aFGF Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Recombinant Human aFGF Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Recombinant Human aFGF Market Share by Country (2021-2026) Table 179. Latin America Recombinant Human aFGF Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Recombinant Human aFGF Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Recombinant Human aFGF Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Recombinant Human aFGF Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Recombinant Human aFGF Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Recombinant Human aFGF Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Recombinant Human aFGF Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Recombinant Human aFGF Market Share by Country (2021-2026) Table 189. Middle East and Africa Recombinant Human aFGF Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Recombinant Human aFGF Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Recombinant Human aFGF Distributors List Table 194. Recombinant Human aFGF Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Recombinant Human aFGF Image Figure 2. Global Recombinant Human aFGF Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human aFGF Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human aFGF Sales (2021-2032) & (k units) Figure 5. Acidic Image Figure 6. Global Acidic Sales YoY Growth (2021-2032) & (k units) Figure 7. Alkaline Image Figure 8. Global Alkaline Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Recombinant Human aFGF Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Human aFGF Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Human aFGF Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Human aFGF Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Human aFGF Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Human aFGF Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Human aFGF Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Human aFGF Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Human aFGF Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Human aFGF Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Human aFGF Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Human aFGF Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Human aFGF Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Biopharmaceuticals Image Figure 24. Global Biopharmaceuticals Sales YoY Growth (2021-2032) & (k units) Figure 25. Cell Culture & Regenerative Medicine Image Figure 26. Global Cell Culture & Regenerative Medicine Sales YoY Growth (2021-2032) & (k units) Figure 27. In Vitro Diagnostics Image Figure 28. Global In Vitro Diagnostics Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Recombinant Human aFGF Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Recombinant Human aFGF Market Share by Application 2025 VS 2032 Figure 33. North America Recombinant Human aFGF Sales Market Share in Volume by Application in 2025 Figure 34. North America Recombinant Human aFGF Sales Market Share in Value by Application in 2025 Figure 35. Europe Recombinant Human aFGF Sales Market Share in Volume by Application in 2025 Figure 36. Europe Recombinant Human aFGF Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Recombinant Human aFGF Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Recombinant Human aFGF Sales Market Share in Value by Application in 2025 Figure 39. Latin America Recombinant Human aFGF Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Recombinant Human aFGF Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Recombinant Human aFGF Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Recombinant Human aFGF Sales Market Share in Value by Application in 2025 Figure 43. North America Recombinant Human aFGF Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Recombinant Human aFGF Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Recombinant Human aFGF Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Recombinant Human aFGF Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Human aFGF Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Recombinant Human aFGF Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant Human aFGF Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Recombinant Human aFGF Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Human aFGF Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Recombinant Human aFGF Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant Human aFGF Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Recombinant Human aFGF Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Human aFGF Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Recombinant Human aFGF Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant Human aFGF Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Recombinant Human aFGF Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Human aFGF Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Recombinant Human aFGF Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant Human aFGF Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Recombinant Human aFGF Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Recombinant Human aFGF Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Recombinant Human aFGF Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Acidic
  • Alkaline
Applications
  • Biopharmaceuticals
  • Cell Culture & Regenerative Medicine
  • In Vitro Diagnostics
  • Others
Companies covered
  • Merck
  • MP Biomedicals
  • Proteintech
  • InVitria
  • Sino Biological
  • Reprokine
  • ACROBiosystems
  • Assay Genie
  • Cell Biologics
  • Sartorius AG
  • Yeasen
  • MedChemExpress
  • Abcam
  • Basic Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human aFGF Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human aFGF Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human aFGF Market by Type
  6. 1.3.1 Acidic
  7. 1.3.2 Alkaline
  8. 1.4 Global Recombinant Human aFGF Market Size by Type
  9. 1.4.1 Global Recombinant Human aFGF Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Human aFGF Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Human aFGF Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Human aFGF Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Human aFGF Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Human aFGF Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Human aFGF Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Human aFGF Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human aFGF Industry Trends
  2. 2.2 Recombinant Human aFGF Industry Drivers
  3. 2.3 Recombinant Human aFGF Industry Opportunities and Challenges
  4. 2.4 Recombinant Human aFGF Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human aFGF Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human aFGF Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human aFGF Price (2021-2026)
  4. 3.4 Global Recombinant Human aFGF Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human aFGF Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human aFGF Company, Product Type & Application
  7. 3.7 Global Recombinant Human aFGF Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human aFGF Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human aFGF Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human aFGF Tier 1, Tier 2, and Tier 3
4 Recombinant Human aFGF Regional Status and Outlook
  1. 4.1 Global Recombinant Human aFGF Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human aFGF Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human aFGF Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human aFGF Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human aFGF Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human aFGF Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human aFGF Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human aFGF Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human aFGF Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human aFGF by Application
  1. 5.1 Recombinant Human aFGF Market by Application
  2. 5.1.1 Biopharmaceuticals
  3. 5.1.2 Cell Culture & Regenerative Medicine
  4. 5.1.3 In Vitro Diagnostics
  5. 5.1.4 Others
  6. 5.2 Global Recombinant Human aFGF Market Size by Application
  7. 5.2.1 Global Recombinant Human aFGF Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Recombinant Human aFGF Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Recombinant Human aFGF Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Recombinant Human aFGF Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Recombinant Human aFGF Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Recombinant Human aFGF Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Recombinant Human aFGF Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Recombinant Human aFGF Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Recombinant Human aFGF Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 MP Biomedicals
  8. 6.2.1 MP Biomedicals Company Information
  9. 6.2.2 MP Biomedicals Business Overview
  10. 6.2.3 MP Biomedicals Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MP Biomedicals Recombinant Human aFGF Product Portfolio
  12. 6.2.5 MP Biomedicals Recent Developments
  13. 6.3 Proteintech
  14. 6.3.1 Proteintech Company Information
  15. 6.3.2 Proteintech Business Overview
  16. 6.3.3 Proteintech Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Proteintech Recombinant Human aFGF Product Portfolio
  18. 6.3.5 Proteintech Recent Developments
  19. 6.4 InVitria
  20. 6.4.1 InVitria Company Information
  21. 6.4.2 InVitria Business Overview
  22. 6.4.3 InVitria Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 InVitria Recombinant Human aFGF Product Portfolio
  24. 6.4.5 InVitria Recent Developments
  25. 6.5 Sino Biological
  26. 6.5.1 Sino Biological Company Information
  27. 6.5.2 Sino Biological Business Overview
  28. 6.5.3 Sino Biological Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sino Biological Recombinant Human aFGF Product Portfolio
  30. 6.5.5 Sino Biological Recent Developments
  31. 6.6 Reprokine
  32. 6.6.1 Reprokine Company Information
  33. 6.6.2 Reprokine Business Overview
  34. 6.6.3 Reprokine Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Reprokine Recombinant Human aFGF Product Portfolio
  36. 6.6.5 Reprokine Recent Developments
  37. 6.7 ACROBiosystems
  38. 6.7.1 ACROBiosystems Company Information
  39. 6.7.2 ACROBiosystems Business Overview
  40. 6.7.3 ACROBiosystems Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ACROBiosystems Recombinant Human aFGF Product Portfolio
  42. 6.7.5 ACROBiosystems Recent Developments
  43. 6.8 Assay Genie
  44. 6.8.1 Assay Genie Company Information
  45. 6.8.2 Assay Genie Business Overview
  46. 6.8.3 Assay Genie Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Assay Genie Recombinant Human aFGF Product Portfolio
  48. 6.8.5 Assay Genie Recent Developments
  49. 6.9 Cell Biologics
  50. 6.9.1 Cell Biologics Company Information
  51. 6.9.2 Cell Biologics Business Overview
  52. 6.9.3 Cell Biologics Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cell Biologics Recombinant Human aFGF Product Portfolio
  54. 6.9.5 Cell Biologics Recent Developments
  55. 6.10 Sartorius AG
  56. 6.10.1 Sartorius AG Company Information
  57. 6.10.2 Sartorius AG Business Overview
  58. 6.10.3 Sartorius AG Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sartorius AG Recombinant Human aFGF Product Portfolio
  60. 6.10.5 Sartorius AG Recent Developments
  61. 6.11 Yeasen
  62. 6.11.1 Yeasen Company Information
  63. 6.11.2 Yeasen Business Overview
  64. 6.11.3 Yeasen Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Yeasen Recombinant Human aFGF Product Portfolio
  66. 6.11.5 Yeasen Recent Developments
  67. 6.12 MedChemExpress
  68. 6.12.1 MedChemExpress Company Information
  69. 6.12.2 MedChemExpress Business Overview
  70. 6.12.3 MedChemExpress Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 MedChemExpress Recombinant Human aFGF Product Portfolio
  72. 6.12.5 MedChemExpress Recent Developments
  73. 6.13 Abcam
  74. 6.13.1 Abcam Company Information
  75. 6.13.2 Abcam Business Overview
  76. 6.13.3 Abcam Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abcam Recombinant Human aFGF Product Portfolio
  78. 6.13.5 Abcam Recent Developments
  79. 6.14 Basic Pharma
  80. 6.14.1 Basic Pharma Company Information
  81. 6.14.2 Basic Pharma Business Overview
  82. 6.14.3 Basic Pharma Recombinant Human aFGF Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Basic Pharma Recombinant Human aFGF Product Portfolio
  84. 6.14.5 Basic Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human aFGF Sales by Country
  2. 7.1.1 North America Recombinant Human aFGF Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human aFGF Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human aFGF Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human aFGF Market Size by Country
  6. 7.2.1 North America Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human aFGF Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human aFGF Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human aFGF Sales by Country
  2. 8.1.1 Europe Recombinant Human aFGF Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human aFGF Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human aFGF Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human aFGF Market Size by Country
  6. 8.2.1 Europe Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human aFGF Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human aFGF Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human aFGF Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human aFGF Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human aFGF Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human aFGF Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human aFGF Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human aFGF Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human aFGF Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human aFGF Sales by Country
  2. 10.1.1 South America Recombinant Human aFGF Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human aFGF Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human aFGF Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human aFGF Market Size by Country
  6. 10.2.1 South America Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human aFGF Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human aFGF Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human aFGF Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human aFGF Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human aFGF Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human aFGF Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human aFGF Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human aFGF Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human aFGF Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human aFGF Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human aFGF Value Chain Analysis
  2. 12.1.1 Recombinant Human aFGF Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human aFGF Production Mode & Process
  7. 12.2 Recombinant Human aFGF Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human aFGF Distributors
  10. 12.2.3 Recombinant Human aFGF Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst